ApoE controls the interface linking lipids and inflammation in atherosclerosis
Christian Weber1, Oliver Soehnlein
1Institute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Munich, Germany. christian.weber@med.uni-muenchen.de
The Journal of Clinical Investigation
|October 5, 2011
Summary
High cholesterol (hypercholesterolemia) and high white blood cell counts (leukocytosis) contribute to atherosclerosis. A new study reveals a mechanistic link between these factors, offering potential new treatments for arterial disease.
Area of Science:
- Cardiovascular Science
- Immunology
- Pathology
Background:
- Atherosclerosis is a chronic inflammatory arterial disease.
- Hypercholesterolemia and leukocytosis are independent risk factors.
- Arterial leukocyte infiltration contributes to disease progression.
Purpose of the Study:
- To identify a mechanistic link between hypercholesterolemia and leukocytosis in atherosclerosis.
- To investigate the role of leukocyte homeostasis in atherosclerotic lesion development.
Main Methods:
- The study utilized a mouse model to investigate the relationship between hypercholesterolemia and leukocytosis.
- Mechanistic pathways connecting these conditions and lesion development were explored.
Main Results:
- Murphy and colleagues identified a mechanistic link between hypercholesterolemia and leukocytosis.
- This link promotes arterial leukocyte infiltration and atherosclerotic lesion formation in mice.
Conclusions:
- Hypercholesterolemia and leukocytosis are mechanistically linked in the development of atherosclerosis.
- Findings suggest novel therapeutic strategies targeting leukocyte homeostasis to manage atherosclerosis.
Related Concept Videos
01:38Inflammation
64.6K
Overview
64.6K
01:31Lipid-derived Compounds in the Human Body
7.4K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
7.4K
01:26Coronary Artery Disease II: Pathophysiology
996
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
996
01:30Atherosclerosis I: Introduction
2.0K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.0K
01:26Atherosclerosis III: Management
592
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
592
01:30Peripheral Artery Disease I: Introduction
638
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
638